TOP GUIDELINES OF GR 113808

quinupristin/dalfopristin will boost the amount or impact of avanafil by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Keep an eye on. CYP3A4 inhibitors could cut down avanafil clearance expanding systemic publicity to avanafil; amplified amounts may end in elevated linked adverse events; the maximum advised dose of STENDRA is